Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Traini

Showing results (111-120 of 246) with videos related to

Pageof 25
Sort By:
Applied Microbiology and Biotechnology|January 11, 2022
An adaptable microreactor to investigate the influence of interfaces on Pseudomonas aeruginosa biofilm growthZhang Ye, Dina M Silva, Daniela Traini, et al.
Molecular Pharmaceutics|April 30, 2015
Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infectionSumit Arora, Mehra Haghi, Ching-Yee Loo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 1, 2008
Micro-particle corrugation, adhesion and inhalation aerosol efficiencySantoso Adi, Handoko Adi, Patricia Tang, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 6, 2013
Overcoming dose limitations using the orbital(®) multi-breath dry powder inhalerPaul M Young, John Crapper, Gary Philips, et al.
International Journal of Pharmaceutics|March 18, 2008
The use of atomic force microscopy to study the conditioning of micronised budesonideMatthew D Jones, Paul M Young, Daniela Traini, et al.
Expert Opinion on Drug Delivery|January 19, 2022
Prospective nanoparticle treatments for lymphangioleiomyomatosisEmelie Landh, Roger Wang, Lyn M Moir, et al.
Journal of Pharmaceutical Sciences|June 23, 2011
Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of the influence of grid structures for agglomerated systemsWilliam Wong, David F Fletcher, Daniela Traini, et al.
Nanomedicine (London, England)|August 22, 2020
Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of sizeEmelie Landh, Lyn M Moir, Peta Bradbury, et al.
Expert Opinion on Drug Delivery|September 23, 2014
Dry powder formulation of simvastatinAlaa S Tulbah, Hui Xin Ong, Lucy Morgan, et al.
Nanomedicine (London, England)|October 4, 2017
Inhaled simvastatin nanoparticles for inflammatory lung diseaseAlaa S Tulbah, Elvira Pisano, Santo Scalia, et al.
Pageof 25

Showing results (111-120 of 246) with videos related to

Sort By:
Pageof 25
Applied Microbiology and Biotechnology|January 11, 2022
An adaptable microreactor to investigate the influence of interfaces on Pseudomonas aeruginosa biofilm growthZhang Ye, Dina M Silva, Daniela Traini, et al.
Molecular Pharmaceutics|April 30, 2015
Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infectionSumit Arora, Mehra Haghi, Ching-Yee Loo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 1, 2008
Micro-particle corrugation, adhesion and inhalation aerosol efficiencySantoso Adi, Handoko Adi, Patricia Tang, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 6, 2013
Overcoming dose limitations using the orbital(®) multi-breath dry powder inhalerPaul M Young, John Crapper, Gary Philips, et al.
International Journal of Pharmaceutics|March 18, 2008
The use of atomic force microscopy to study the conditioning of micronised budesonideMatthew D Jones, Paul M Young, Daniela Traini, et al.
Expert Opinion on Drug Delivery|January 19, 2022
Prospective nanoparticle treatments for lymphangioleiomyomatosisEmelie Landh, Roger Wang, Lyn M Moir, et al.
Journal of Pharmaceutical Sciences|June 23, 2011
Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of the influence of grid structures for agglomerated systemsWilliam Wong, David F Fletcher, Daniela Traini, et al.
Nanomedicine (London, England)|August 22, 2020
Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of sizeEmelie Landh, Lyn M Moir, Peta Bradbury, et al.
Expert Opinion on Drug Delivery|September 23, 2014
Dry powder formulation of simvastatinAlaa S Tulbah, Hui Xin Ong, Lucy Morgan, et al.
Nanomedicine (London, England)|October 4, 2017
Inhaled simvastatin nanoparticles for inflammatory lung diseaseAlaa S Tulbah, Elvira Pisano, Santo Scalia, et al.
Pageof 25